Cargando…

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression

BACKGROUND: Hypertension is a multi-factorial disease of increasing prevalence and a major risk factor for cardiovascular mortality even in the presence of adequate treatment. Progression of cardiovascular disease (CVD) occurs frequently during chronic renin-angiotensin-system (RAS) suppression, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Calero, Laura, Martin-Lorenzo, Marta, de la Cuesta, Fernando, Maroto, Aroa S., Baldan-Martin, Montserrat, Ruiz-Hurtado, Gema, Pulido-Olmo, Helena, Segura, Julian, Barderas, Maria G., Ruilope, Luis M., Vivanco, Fernando, Alvarez-Llamas, Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715311/ https://www.ncbi.nlm.nih.gov/pubmed/26772976 http://dx.doi.org/10.1186/s12933-016-0331-7

Ejemplares similares

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
por: Martin-Lorenzo, Marta, et al.
Publicado: (2017)

Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria
por: Gonzalez-Calero, Laura, et al.
Publicado: (2017)

Author Correction: Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria
por: Martin-Lorenzo, Marta, et al.
Publicado: (2018)

Kalirin and CHD7: novel endothelial dysfunction indicators in circulating extracellular vesicles from hypertensive patients with albuminuria
por: de la Cuesta, Fernando, et al.
Publicado: (2017)

Progression of Renal Insufficiency in Patients with Essential Hypertension Treated with Renin Angiotensin Aldosterone System Blockers: An Electrocardiographic Correlation
por: Rodriguez-Padial, Luis, et al.
Publicado: (2017)

A comprehensive study of calcific aortic stenosis: from rabbit to human samples
por: Mourino-Alvarez, Laura, et al.
Publicado: (2018)

Urinary metabolic signatures reflect cardiovascular risk in the young, middle-aged, and elderly populations
por: Martinez, Paula J., et al.
Publicado: (2020)

KLK1 and ZG16B proteins and arginine–proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery
por: Martin-Lorenzo, Marta, et al.
Publicado: (2014)

Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9–Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA Technology: A New Alternative to Classical ELISA
por: Pulido-Olmo, Helena, et al.
Publicado: (2017)

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension
por: Santiago-Hernandez, Aranzazu, et al.
Publicado: (2021)

Lipid and protein maps defining arterial layers in atherosclerotic aorta
por: Martin-Lorenzo, Marta, et al.
Publicado: (2015)

Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals
por: Baldan-Martin, Montserrat, et al.
Publicado: (2018)

Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?
por: Gonzalez-Calero, Laura, et al.
Publicado: (2016)

Metabolomic Profiling for Identification of Novel Potential Biomarkers in Cardiovascular Diseases
por: Barderas, Maria G., et al.
Publicado: (2011)

Microalbuminuria and cardiorenal risk: old and new evidence in different populations
por: Márquez, Diego Francisco, et al.
Publicado: (2019)

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers
por: Heerspink, H. J. L., et al.
Publicado: (2016)

Valvular Aortic Stenosis: A Proteomic Insight
por: Gil-Dones, Felix, et al.
Publicado: (2010)

Age and blood pressure goal in women with prior coronary events
por: Ruilope, Luis M., et al.
Publicado: (2020)

Proteomic Biomarkers of Atherosclerosis
por: Vivanco, F., et al.
Publicado: (2008)

Comparison of spironolactone and trichlormethiazide as add‐on therapy to renin–angiotensin blockade for reduction of albuminuria in diabetic patients
por: Hase, Michiyo, et al.
Publicado: (2013)

A Molecular (Not Very Becoming) Picture of Stressed Arteries and Heart, with Some Therapeutic Hope
por: Barderas, Maria G., et al.
Publicado: (2023)

Albuminuria and the Duration of Albuminuria in Cholera
por: Brahmachari, U. N.
Publicado: (1907)

The impact of antihypertensives on kidney disease
por: Marquez, Diego F, et al.
Publicado: (2017)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative Stress
por: González-Blázquez, Raquel, et al.
Publicado: (2018)

Albuminuria
Publicado: (1890)

Albuminuria
por: Ballenger, Edgar
Publicado: (1908)

Albuminuria
Publicado: (1883)

Albuminuria
por: Reed, W. L.
Publicado: (1893)

Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease
por: Gómez-Mariano, Gema, et al.
Publicado: (2019)

Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome
por: Laborde, Carlos M., et al.
Publicado: (2013)

Aliskiren suppresses the renin–angiotensin–aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin–angiotensin system inhibitors in type 2 diabetic patients with albuminuria
por: Cooper, Mark E., et al.
Publicado: (2019)

Oxidized Low-Density Lipoprotein Associates with Ventricular Stress in Young Adults and Triggers Intracellular Ca(2+) Alterations in Adult Ventricular Cardiomyocytes
por: Rodríguez-Sánchez, Elena, et al.
Publicado: (2020)

Can patiromer allow for intensified renin–angiotensin–aldosterone system blockade with losartan and spironolactone leading to decreased albuminuria in patients with chronic kidney disease, albuminuria and hyperkalaemia? An open-label randomised controlled trial: MorphCKD
por: Mårup, Frederik Husum, et al.
Publicado: (2022)

Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial
por: Larsen, Thomas, et al.
Publicado: (2013)

Physiological Albuminuria
Publicado: (1905)

Athletics and Albuminuria
Publicado: (1907)

Albuminuria in Pregnancy
por: Statham, R. S. S.
Publicado: (1932)

Albuminuria in Pregnancy
por: Nixon, J. A.
Publicado: (1932)

Cannot write session to /tmp/vufind_sessions/sess_v29h88jnbtpvku34vp82ce55e2